Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Beijing SL Pharmaceutical Co., Ltd.
—
Beijing SL Pharmaceutical Co., Ltd. is led by CEO Mingbo Xu, employs 901 people, headquartered in Beijing, CN, publicly traded since 2004.
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) stock trades at $5.08 with a market capitalization of $5.79B. The stock is valued at a negative price-to-earnings (P/E) ratio of -13.41, reflecting a net loss over the last twelve months, price-to-book of 1.10, price-to-sales of 10.16. Over the past 52 weeks the stock has ranged between $4.81 and $9.40, and currently trades 46.0% below its 52-week high. It pays a dividend yielding 0.18%.
On profitability, Beijing SL Pharmaceutical Co., Ltd. generates a return on equity (ROE) of -13.63% (negative, reflecting a net loss), an operating margin of -27.63%, a net profit margin of -126.84%.
Official website: www.slpharm.com.cn
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) — frequently asked questions
What is Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) stock price today?
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is currently trading at $5.08, down 2.5% today.
What is 002038.SZ P/E ratio?
Beijing SL Pharmaceutical Co., Ltd.'s P/E ratio is -13.41. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 002038.SZ return on equity (ROE)?
Beijing SL Pharmaceutical Co., Ltd.'s return on equity (ROE) is -13.63%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Beijing SL Pharmaceutical Co., Ltd.'s market cap?
Beijing SL Pharmaceutical Co., Ltd. has a market capitalization of $5.79B.
Does 002038.SZ pay a dividend?
Yes. Beijing SL Pharmaceutical Co., Ltd. currently yields 0.18%. Yield moves with the share price, so it changes daily even when the payment does not.
What is 002038.SZ's profit margin?
Beijing SL Pharmaceutical Co., Ltd. reports a net profit margin of -126.84% — the share of revenue left after every cost, including tax and interest.
What sector is 002038.SZ in?
Beijing SL Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002038.SZ listed on?
Beijing SL Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002038.SZ.
What is 002038.SZ's 52-week range?
Over the last year Beijing SL Pharmaceutical Co., Ltd. has traded between $4.81 and $9.40.
Related — Stocks
Popular Stocks
Screens 002038.SZ currently matches
On the figures above, Beijing SL Pharmaceutical Co., Ltd. passes the filters for 6 of our ready-made screens, among them Stocks Under $10, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.